Caplin Steriles Limited (Caplin), a Subsidiary of Caplin Point Labs has been granted final
approval from the United States Food and Drug Administration (USFDA) for its Abbreviated
New Drug Application (ANDA) Phenylephrine hydrochloride Ophthalmic Solution USP 2.5%
and 10% (eye drops)
Caplin steriles has been outperforming in the US marketa and this approvel will only strengthen its position in US further, more ANDA’s are expected to get approval for Caplin Point Labs in FY25.
Disc : Not a buy/sell recommendation.
Subscribe To Our Free Newsletter |